Progress in concept study

Futura Medical PLC
23 February 2004


Press Release                                                  23 February 2004



                  Futura Medical plc announces early progress
                           in proof of concept study

Futura Medical plc ('Futura'), the AIM-quoted pharmaceutical and medical device
group that develops innovative products for the sexual healthcare market,
announces that an effective, simple technique for instilling measured doses of
gel containing a vasodilator during continuous vaginal photoplethysmography, a
diagnostic method of measuring blood flow, has been developed by the clinical
team who are conducting a proof of concept study at the Porterbrook Clinic in
Sheffield.

The technique has allowed the measurement of a difference in vaginal blood
circulation (a surrogate marker for lubrication) between the application of an
active gel and a placebo gel.

This information will be published in the form of a poster at the upcoming
conferences:
          
•    7th Congress of the European Federation of Sexology in Brighton, 12-16 
     May 2004
     
•    International Academy Sex Research  (IASR) meeting In Helsinki, 16-20
     June 2004

•    International Society for the Study of Women's Sexual Health (ISWSSH), 
     summer 2004

James Barder, Chief Executive of Futura Medical plc, said: 'Whilst we are
pleased with the initial progress of the female proof of concept study, this
needs to be completed before any conclusions can be drawn.  The purpose of the
announcement is to enable the Porterbrook Clinic openly to discuss its clinical
study methodology at these forthcoming important sexual health conferences as
agreed under the terms of the study contract.'

For further information:
Futura Medical plc
James Barder, Chief Executive                          Tel: [phone]
Email: [e-mail]                  www.futuramedical.co.uk

Media enquiries:
Bankside
Henry Harrison-Topham / Alex Tweed                     Tel: [phone]
Email: [e-mail]                             www.bankside.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange